These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 20356692)
1. Should bisphosphonates be used in premenopausal women? Cohen A Maturitas; 2010 May; 66(1):3-4. PubMed ID: 20356692 [No Abstract] [Full Text] [Related]
2. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw? Thompson E; Sheehy C; Barry M; Carey J Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507 [No Abstract] [Full Text] [Related]
6. Treating osteoporosis. Smith G; Stassen L; Flint S Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199 [No Abstract] [Full Text] [Related]
7. Bisphosphonates for osteoporosis: benefits and risks. Bollerslev J; Harris ST; Leder BZ J Clin Endocrinol Metab; 2011 Sep; 96(9):27A, 28A. PubMed ID: 21896893 [No Abstract] [Full Text] [Related]
8. Bisphosphonates and bone turnover in premenopausal women receiving adjuvant chemotherapy. Paterson A; Baker T J Clin Oncol; 2009 Mar; 27(7):1005-6. PubMed ID: 19171701 [No Abstract] [Full Text] [Related]
9. Can the bisphosphonate I'm taking for osteoporosis actually cause a bone fracture? Johns Hopkins Med Lett Health After 50; 2011 Oct; 23(8):7. PubMed ID: 22059260 [No Abstract] [Full Text] [Related]
10. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis. Horning JA; Czajka J; Uhl RL Orthopedics; 2010 Dec; 33(12):902. PubMed ID: 21117565 [No Abstract] [Full Text] [Related]
11. [Metabolic bone diseases: benefits and risks of the treatment]. Rizzoli R Rev Med Suisse; 2009 Jun; 5(207):1299-300. PubMed ID: 19626928 [No Abstract] [Full Text] [Related]
12. Bisphosphonates and osteoporosis: which therapeutic agent is best? Bannon M QJM; 2011 Apr; 104(4):279-80. PubMed ID: 21421549 [No Abstract] [Full Text] [Related]
13. [The successful development of bisphosphonates in the therapy of osteoporosis]. Fassbender WJ; Stumpf UC; Kurth A Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363 [TBL] [Abstract][Full Text] [Related]
17. Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS). Sanders J; Crawford B; Gibson J; Joy Ho P; Iland H; Joshua D Int J Lab Hematol; 2007 Oct; 29(5):395-7. PubMed ID: 17824924 [No Abstract] [Full Text] [Related]
18. Intravenous bisphosphonates in osteoporosis and jaw osteonecrosis: comment on the article by Delmas et al. Landis BN; Hugentobler M Arthritis Rheum; 2006 Nov; 54(11):3720-1; author reply 3721-2. PubMed ID: 17075888 [No Abstract] [Full Text] [Related]